We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Common FDA, EMA Guidance on Orphan Protocol Needed, Experts Say
Common FDA, EMA Guidance on Orphan Protocol Needed, Experts Say
April 13, 2012
To help drugmakers speed new therapies to patients with rare diseases, U.S. and EU regulators should harmonize their philosophies around orphan drug protocol and generate common guidance, experts say.